MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Change in Account Payables of -$10.0 million for Q4 2025, down 1742.08% on a QoQ basis from $606000.0 in Q3 2025, and down 202.83% year-over-year from $9.7 million in Q4 2024.
MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$10.0 million for Q4 2025.
- Quarterly Change in Account Payables fell 202.83% year-over-year to -$10.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.3 million (down 214.67% YoY) and the FY2025 annual result came in at -$12.3 million, down 214.67% from the prior year.
- Change in Account Payables was -$10.0 million for Q4 2025 at MeiraGTx Holdings, down from $606000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $14.6 million in Q1 2023 and bottomed at -$10.0 million in Q4 2025.
- A 5-year average of $891950.0 and a median of $539000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 770.88% — and 2023, when it sank 256.01%.
- MeiraGTx Holdings' Change in Account Payables stood at $9.4 million in 2021, then plunged by 151.76% to -$4.9 million in 2022, then surged by 37.37% to -$3.1 million in 2023, then decreased by 7.28% to -$3.3 million in 2024, then sank by 202.83% to -$10.0 million in 2025.
- Business Quant data shows MGTX's Change in Account Payables at -$10.0 million in Q4 2025, $606000.0 in Q3 2025, and $93000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - | -9.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.95 Mn |
| Dec 31, 2025 | -9.95 Mn |
| Sep 30, 2025 | 606,000.00 |
| Sep 30, 2025 | 606,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -3.06 Mn |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 5.20 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Sep 30, 2023 | -7.68 Mn |
| Sep 30, 2023 | -7.68 Mn |